In Panama, adult patients with type 2 diabetes now have a new therapeutic option to manage their condition. AstraZeneca has announced the launch of Sidapvia, a new oral treatment that combines two innovative components in a single tablet for more effective control of blood glucose levels, providing additional health benefits to the patient.
Sidapvia combines dapagliflozin and sitagliptin in one tablet, two molecules with complementary mechanisms that help the body naturally eliminate excess sugar, enhancing insulin action and maintaining a more stable glucose balance throughout the day. Clinical studies have demonstrated that the drug achieves a significant reduction in blood sugar, along with additional benefits such as decreased body weight, blood pressure, and risks of heart and kidney complications, allowing for a comprehensive approach to different aspects of the disease and offering a more practical, effective option aligned with the patient's long-term management needs.
"With Sidapvia, we aim to transform the care and needs of type 2 diabetes patients by promoting the comprehensive management of their metabolic health. By combining two medications in a single tablet, we simplify the treatment and improve therapeutic adherence," stated Dr. Andrés Rojas, Medical Director of AstraZeneca for Central America and the Caribbean.
Type 2 Diabetes: A Growing Challenge
Type 2 diabetes is one of the most common chronic diseases worldwide and a leading cause of serious complications, such as blindness, kidney failure, heart attack, stroke, and lower limb amputation. According to the International Diabetes Federation (IDF), over 400 million adults worldwide have the disease, with 90% developing type 2 diabetes. These numbers are expected to increase by 46% by 2045.
"Lack of proper control of blood glucose levels increases the risk of compromising vital organs, such as the heart and kidneys. Complications in these patients are growing daily due to a lack of education and information, making it essential to raise awareness and provide comprehensive support from healthcare professionals," indicated Dr. Rojas.
Among the most frequent symptoms are excessive thirst, increased urination, unexplained weight loss, blurred vision, fatigue, slow-healing wounds, recurrent infections, and tingling or numbness in the hands and feet. Early diagnosis is key to preventing serious complications and achieving better disease control.
